347 related articles for article (PubMed ID: 33853649)
1. Clinical features and disease severity in patients with mosaic neurofibromatosis type 1: a single-center study and literature review.
Ejerskov C; Raundahl M; Gregersen PA; Handrup MM
Orphanet J Rare Dis; 2021 Apr; 16(1):180. PubMed ID: 33853649
[TBL] [Abstract][Full Text] [Related]
2. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
[TBL] [Abstract][Full Text] [Related]
3. Mosaic Neurofibromatosis Type 1: A Systematic Review.
García-Romero MT; Parkin P; Lara-Corrales I
Pediatr Dermatol; 2016; 33(1):9-17. PubMed ID: 26338194
[TBL] [Abstract][Full Text] [Related]
4. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.
Waggoner DJ; Towbin J; Gottesman G; Gutmann DH
Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438
[TBL] [Abstract][Full Text] [Related]
5. Mosaic Neurofibromatosis Type 1 With Multiple Cutaneous Diffuse and Plexiform Neurofibromas of the Lower Leg.
Friedrich RE; Hagel C; Kohlrusch FK; Schanze I; Wieland I; Zenker M
Anticancer Res; 2020 Jun; 40(6):3423-3427. PubMed ID: 32487640
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous and Systemic Findings in Mosaic Neurofibromatosis Type 1.
Vázquez-Osorio I; Duat-Rodríguez A; García-Martínez FJ; Torrelo A; Noguera-Morel L; Hernández-Martín A
Pediatr Dermatol; 2017 May; 34(3):271-276. PubMed ID: 28318056
[TBL] [Abstract][Full Text] [Related]
7. Is a plexiform neurofibroma pathognomonic of neurofibromatosis type I?
Lin V; Daniel S; Forte V
Laryngoscope; 2004 Aug; 114(8):1410-4. PubMed ID: 15280718
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas.
Overdiek A; Feifel H; Schaper J; Mayatepek E; Rosenbaum T
Brain Dev; 2006 Jun; 28(5):275-80. PubMed ID: 16481142
[TBL] [Abstract][Full Text] [Related]
9. Oral manifestations of neurofibromatosis type 1 in children with facial plexiform neurofibroma: report of three cases.
Cunha KS; Rozza-de-Menezes RE; Andrade RM; Almeida L; Janini M; Geller M
J Clin Pediatr Dent; 2015; 39(2):168-71. PubMed ID: 25823487
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of 58 Japanese patients with mosaic neurofibromatosis 1.
Tanito K; Ota A; Kamide R; Nakagawa H; Niimura M
J Dermatol; 2014 Aug; 41(8):724-8. PubMed ID: 25041723
[TBL] [Abstract][Full Text] [Related]
11. Visual outcomes in children with neurofibromatosis type 1 and orbitotemporal plexiform neurofibromas.
Avery RA; Dombi E; Hutcheson KA; Acosta MT; Baldwin AM; Madigan WP; Gillespie A; Fitzgibbon EJ; Packer RJ; Widemann BC
Am J Ophthalmol; 2013 Jun; 155(6):1089-1094.e1. PubMed ID: 23453281
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
[TBL] [Abstract][Full Text] [Related]
13. Giant gluteal and vesical plexiform neurofibromas in a patient with neurofibromatosis type 1: a case report.
Sassi I; Bouida MA; Hasnaoui A; Zemni I; Ben Dhieb T
J Med Case Rep; 2024 Jan; 18(1):15. PubMed ID: 38216958
[TBL] [Abstract][Full Text] [Related]
14. Head circumference and anthropometric changes and their relation to plexiform and skin neurofibromas in sporadic and familial neurofibromatosis 1 Brazilian adults: a cross-sectional study.
Basto DL; de Souza Vieira G; Andrade-Losso RM; Almeida PN; Riccardi VM; Rozza-de-Menezes RE; Cunha KS
Orphanet J Rare Dis; 2022 Sep; 17(1):341. PubMed ID: 36064430
[TBL] [Abstract][Full Text] [Related]
15. Predictors of cognitive development in children with neurofibromatosis type 1 and plexiform neurofibromas.
Hou Y; Allen T; Wolters PL; Toledo-Tamula MA; Martin S; Baldwin A; Reda S; Gillespie A; Goodwin A; Widemann BC
Dev Med Child Neurol; 2020 Aug; 62(8):977-984. PubMed ID: 32052421
[TBL] [Abstract][Full Text] [Related]
16. Superimposed Mosaicism in the Form of Extremely Extended Segmental Plexiform Neurofibroma Caused by a Novel Pathogenic Variant in the NF1 Gene.
Veres K; Bene J; Hadzsiev K; Garami M; Pálla S; Happle R; Medvecz M; Szalai ZZ
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569527
[TBL] [Abstract][Full Text] [Related]
17. Verbal learning and memory in youth with neurofibromatosis type 1 and plexiform neurofibromas: Relationships with disease severity.
Loucas C; Wolters P; Toledo-Tamula MA; Rhodes A; Baldwin A; Goodwin A; Widemann B; Martin S
Eur J Paediatr Neurol; 2022 May; 38():7-12. PubMed ID: 35334353
[TBL] [Abstract][Full Text] [Related]
18. [Unilateral facial and cerebral hyperplasia associated with neurofibromatosis type 1. Report of four patients].
Pascual-Castroviejo I; Pascual-Pascual SI; Burgueno M; Martin-Perez M; Palencia R; Garcia-Segura JM; Valero C
Rev Neurol; 2006 Sep 16-30; 43(6):346-52. PubMed ID: 16981165
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas.
Tucker T; Friedman JM; Friedrich RE; Wenzel R; Fünsterer C; Mautner VF
J Med Genet; 2009 Feb; 46(2):81-5. PubMed ID: 18930997
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and follow-up protocol for adult patients with neurofibromatosis type 1 in a Spanish reference unit.
Solares I; Vinal D; Morales-Conejo M
Rev Clin Esp (Barc); 2022 Oct; 222(8):486-495. PubMed ID: 35688675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]